Navigation Links
Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Date:10/29/2008

nd administrative expenses were $2.6 million for the third quarter of 2008, compared to $1.7 million for the same period in 2007. The increase in general and administrative expenses was primarily due to increased personnel costs, including non-cash stock-based compensation which totaled $709,000 in the third quarter of 2008 compared to $202,000 in the same period in 2007.

Total operating expenses for the third quarter of 2008 were $10.1 million, compared to $7.6 million for the same period in 2007.

Net interest and other income was $42,000 for the third quarter of 2008, compared to $1.1 million for the same period in 2007. The decrease is due to lower average investment balances and lower interest rates as well as a foreign currency translation loss during the quarter.

Nine Month Results

For the nine months ended September 30, 2008, the consolidated net loss was $21.7 million, or $0.53 per share, compared to a net loss of $14.8 million, or $0.41 per share, for the nine-month period ended September 30, 2007. Revenues were $9.4 million for the first nine months of 2008, compared to $6.3 million in the same period in 2007. Total operating expenses were $32.5 million for the first nine months of 2008 and $23.5 million for the same period of 2007. The increase in operating expenses for 2008 was primarily associated with Sangamo's clinical development programs in diabetic neuropathy and pre-IND programs to develop ZFP Therapeutics for the treatment of HIV/AIDS and glioblastoma, as well as increased research and development personnel costs and lab supply expenses.

Recent Highlights

* Initiation of a Phase 2 clinical trial (SB-509-801) to evaluate SB-509

in subjects with Amyotrophic Lateral Sclerosis (ALS). ALS is a

progressive, degenerative motor-neuron disease for which there are

limited treatment options and no cure. The Phase 2 trial is a

randomized repeat-dosing, open-label, multi-cen
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
3. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
4. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
5. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
6. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
7. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
8. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
9. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
10. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Rust removal is one of home maintenance's essential processes. ... damaged. To help rust contractors make it less expensive, My ... remover it called Rusterizer. It announced that for this ... My Cleaning Products explained that rust could damage items in ... The first one, it said, happens when rust forms ...
(Date:5/16/2013)... May 16, 2013 The Stirling ... Global Cooling, Inc., Athens, OH, USA, won the Outstanding ... the International Society for Biological and Environmental Repositories (ISBER) ... given to one product annually, recognizes the company’s development ... temperature freezer. The award was presented to Global ...
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... software solutions, today announces new Phase II SBIR ... the continued development of an open-source, high performance ... model-centric integration framework enables researchers to select only ... set of simulation, computation, or analysis tasks. ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today ... month period ended March 31, 2008., "We ... total of nine,clinical trials, four exploring the use ... use of REOLYSIN(R) in combination with a variety ...
... Squibb,Company (NYSE: BMY ) invites investors and the ... meeting with stockholders at 10 a.m. ET on Tuesday,May ... items to be,transacted, senior executives will review the status ... listen to the webcast, please visit the,Investor Relations page ...
... Training Institute joins the SURGEX(TM) Team, ... Inc., wholly-owned subsidiary of Millennium Biotechnologies,Group, Inc. ... SURGEX(TM) has,become the official sports nutrition drink ... Florida,s premier basketball training facility for,NBA stars ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces 2008 First Quarter Results 2Oncolytics Biotech Inc. Announces 2008 First Quarter Results 3Oncolytics Biotech Inc. Announces 2008 First Quarter Results 4Oncolytics Biotech Inc. Announces 2008 First Quarter Results 5Oncolytics Biotech Inc. Announces 2008 First Quarter Results 6Oncolytics Biotech Inc. Announces 2008 First Quarter Results 7Oncolytics Biotech Inc. Announces 2008 First Quarter Results 8Oncolytics Biotech Inc. Announces 2008 First Quarter Results 9Oncolytics Biotech Inc. Announces 2008 First Quarter Results 10Oncolytics Biotech Inc. Announces 2008 First Quarter Results 11Oncolytics Biotech Inc. Announces 2008 First Quarter Results 12Oncolytics Biotech Inc. Announces 2008 First Quarter Results 13Oncolytics Biotech Inc. Announces 2008 First Quarter Results 14Oncolytics Biotech Inc. Announces 2008 First Quarter Results 15Oncolytics Biotech Inc. Announces 2008 First Quarter Results 16Oncolytics Biotech Inc. Announces 2008 First Quarter Results 17Oncolytics Biotech Inc. Announces 2008 First Quarter Results 18Oncolytics Biotech Inc. Announces 2008 First Quarter Results 19Oncolytics Biotech Inc. Announces 2008 First Quarter Results 20Oncolytics Biotech Inc. Announces 2008 First Quarter Results 21Oncolytics Biotech Inc. Announces 2008 First Quarter Results 22Oncolytics Biotech Inc. Announces 2008 First Quarter Results 23Oncolytics Biotech Inc. Announces 2008 First Quarter Results 24Oncolytics Biotech Inc. Announces 2008 First Quarter Results 25Oncolytics Biotech Inc. Announces 2008 First Quarter Results 26Oncolytics Biotech Inc. Announces 2008 First Quarter Results 27Oncolytics Biotech Inc. Announces 2008 First Quarter Results 28Oncolytics Biotech Inc. Announces 2008 First Quarter Results 29Oncolytics Biotech Inc. Announces 2008 First Quarter Results 30Oncolytics Biotech Inc. Announces 2008 First Quarter Results 31Oncolytics Biotech Inc. Announces 2008 First Quarter Results 32Oncolytics Biotech Inc. Announces 2008 First Quarter Results 33SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility 2SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility 3
(Date:5/18/2013)... Orlando, FL (May 18, 2013) An increasing ... that require interventions to resolve, according to research ... In one study targeting obesity, researchers at the ... have a unique pattern of exhaled breath compared ... in volatile organic compound levels that can be ...
(Date:5/17/2013)... of New Jersey, and City University of New York ... that effectively clears organisms to be viewed under ... hydrate, which is one of the few high-quality clearing ... the Drug Enforcement Administration (DEA) due to its use ... are vital for viewing organisms under a microscope. Without ...
(Date:5/17/2013)... 17, 2013, Shenzhen, China---- Why Tibetan antelope can ... Plateau? In a collaborative research published in ... and other institutes provide evidence that some genetic ... to harsh highland environments. The data in this ... genetic mechanisms and the biology of other ruminant ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... 15, 2012 ChromaDex Corporation (OTCBB: CDXC) an ... solutions and ingredients to the dietary supplement, food ... financial results for the fiscal year ended December ... accordance with United States Generally Accepted Accounting Principles ...
... , , , , , , ... , , AUDIO: This ... , Click here for more information. , ... , , , , ...
... with conservation tillage increases, more growers are encountering slugs, ... virtually all crops, and they are challenging to control ... are available. In "Slug (Mollusca: Agriolimacidae, Arionidae) Ecology ... on the mid-Atlantic Region," a free, open-access article appearing ...
Cached Biology News:ChromaDex® Announces Financial Results for the Year Ended 2011 2ChromaDex® Announces Financial Results for the Year Ended 2011 3ChromaDex® Announces Financial Results for the Year Ended 2011 4ChromaDex® Announces Financial Results for the Year Ended 2011 5Common North American frog identified as carrier of deadly amphibian disease 2Common North American frog identified as carrier of deadly amphibian disease 3Common North American frog identified as carrier of deadly amphibian disease 4
... stored within neurons in vesicles called ... the synaptic bouton. Synaptosomes may ... from other cellular debris. Abnormalites in ... many pathological condtions. Conditions of ...
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z71,515-8) or ...
... of your microarray data using Asuragens ... you need from consultation to extensive ... to date methods. Utilize our expertise ... Profiling Service or from your own ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
Biology Products: